日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reply to: Late Nonrelapse Mortality: A Hidden Risk in Triplet Therapy for IDH-Mutated AML?

回复:晚期非复发死亡率:IDH突变型急性髓系白血病三联疗法中的潜在风险?

Marvin-Peek, Jennifer; DiNardo, Courtney D

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML

BRG1/BRM抑制剂联合BET抑制剂或地西他滨治疗高危MECOM重排急性髓系白血病疗效显著。

Fiskus, Warren; Mill, Christopher P; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Birdwell, Christine E; Das, Kaberi; Davis, John A; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Kadia, Tapan M; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Wang, Jian; Loghavi, Sanam; Su, Xiaoping; DiNardo, Courtney D; Delwel, Ruud; Bhalla, Kapil N

Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies

维奈托克治疗相关非核心结合因子急性髓系白血病的疗效

Senapati, Jayastu; Croden, Jennifer; Garcia-Manero, Guillermo; Takahashi, Koichi; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Short, Nicholas James; Jabbour, Elias; Haddad, Fadi; Marvin-Peek, Jennifer; Abbas, Hussein A; Bose, Prithviraj; Tang, Guilin; Loghavi, Sanam; Shpall, Elizabeth J; Ramdial, Jeremy; Popat, Uday R; Champlin, Richard E; Ravandi, Farhad; Kantarjian, Hagop M; Dinardo, Courtney D

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML

基于BET抑制剂的联合疗法靶向MECOM重排(r) AML中的新型依赖性

Birdwell, Christine E; Fiskus, Warren; Mill, Christopher P; Kadia, Tapan M; Daver, Naval; DiNardo, Courtney D; Sasaki, Koji; Davis, John A; Das, Kaberi; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Pourebrahim, Rasoul; Yuan, Selina; Su, Xiaoping; Ceribelli, Michele; Bhalla, Kapil N

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes

异基因造血干细胞移植对高危骨髓增生异常综合征患者的影响

Bazinet, Alexandre; Bataller, Alex; Chien, Kelly; Sasaki, Koji; Montalban-Bravo, Guillermo; Hammond, Danielle; Bouligny, Ian; Swaminathan, Mahesh; Jen, Wei Ying; Kugler, Eitan; Kanagal-Shamanna, Rashmi; Kadia, Tapan; Borthakur, Gautam; DiNardo, Courtney; Short, Nicholas; Pemmaraju, Naveen; Jabbour, Elias; Daver, Naval; Ravandi, Farhad; Urrutia, Samuel; Gener-Ricos, Georgina; Braish, Julie; Briski, Robert; Rodriguez-Sevilla, Juan Jose; Li, Ziyi; Champlin, Richard E; Shpall, Elizabeth J; Alousi, Amin; Oran, Betul; Hosing, Chitra; Ramdial, Jeremy L; Olson, Amanda; Pierce, Sherry; Chen, Julianne; Kantarjian, Hagop; Garcia-Manero, Guillermo; Popat, Uday

Host- and pathogen-related determinants of pulmonary versus extrapulmonary tuberculosis

肺结核与肺外结核的宿主和病原体相关决定因素

Tulu, Begna; Brehm, Thomas Theo; van Crevel, Reinout; Dallenga, Tobias; DiNardo, Andrew R; Dheda, Keertan; Eggeling, Johanna; Enbiale, Wendemagegn; Gröschel, Matthias I; Hao, Jialun; Kumar, Vinod; van Laarhoven, Arjan; Londt, Rolanda; Prosser, Gareth; Randall, Philippa; Reiling, Norbert; Rybniker, Jan; Schaible, Ulrich E; Schurr, Erwin; Suarez, Isabelle; Theobald, Sebastian J; Wilkinson, Robert J; Lange, Christoph

Acute myeloid leukemia with t(10;17)(p15;q21)/ ZMYND11::MBTD1: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults

t(10;17)(p15;q21)/ZMYND11::MBTD1 型急性髓系白血病:一种分化程度低、CD7/CD56 表达阳性且成人预后通常较差的亚型

Wei, Qing; Pemmaraju, Naveen; Wang, Sa A; Hu, Shimin; Dinardo, Courtney; Issa, Ghayas C; Bueso-Ramos, Carlos E; Xu, Jie; Li, Shaoying; Medeiros, L Jeffrey; Tang, Guilin

Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor

一线去甲基化药物维奈托克联合FLT3抑制剂治疗FLT3突变型急性髓系白血病患者的长期疗效

Short, Nicholas J; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; Dinardo, Courtney D; Kadia, Tapan M; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J; Popat, Uday; Patel, Keyur P; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval

Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

对不适合接受强化化疗的急性髓系白血病患者进行低剂量阿糖胞苷和维奈托克治疗的风险分层

Wei, Andrew H; Panayiotidis, Panayiotis; Montesinos, Pau; Laribi, Kamel; Ivanov, Vladimir; Kim, Inho; Novak, Jan; Champion, Rebecca; Fiedler, Walter; Pagoni, Maria; Bergeron, Julie; Ting, Stephen B; Hou, Jing-Zhou; Yamauchi, Takahiro; Wang, Jianxiang; Strickland, Stephen A; Savona, Michael R; Lin, Tara L; Enjeti, Anoop; Tiong, Ing Soo; Lee, Sangmin; Roboz, Gail J; Popovic, Relja; Jiang, Qi; Liu, Zihuan; Sun, Yan; Mendes, Wellington; Chyla, Brenda; DiNardo, Courtney D

Clinical, genetic, and familial features of POT1 tumor predisposition syndrome

POT1肿瘤易感综合征的临床、遗传和家族特征

DiNardo, Courtney D; Croden, Jennifer; Abdel-Salam, Hiam M; Kadia, Tapan; Molica, Matteo; Bazinet, Alexandre; Bose, Prithviraj; Maiti, Abhishek; Haddad, Fadi; Burger, Jan; Kantarjian, Hagop; Wierda, William; Jain, Nitin; Ferrajoli, Alessandra